CANLI
Yükleniyor Veriler getiriliyor…
SCI-Expanded JCR Q3 Özgün Makale Scopus
The effect of calcium channel blocker (CCB) treatment on retinal and choroidal vessels in a group of hypertensive patients.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2022 Cilt 44 Sayı 7
Scopus Eşleşmesi Bulundu
1
Atıf
44
Cilt
649-655
Sayfa
Özet
Purpose: The present study was designed to observe the vasoreactivity in retina and choroid after calcium channel blocker (CCB) treatment in a group of hypertensive patients. Method: The study was based on 56 hypertensive patients (56 eyes) and 56 control subjects (56 eyes). Choroidal scans and the measurement of peripapillary retinal vessel diameters was performed at baseline and optical coherence tomography (OCT) scans were also performed at first month. Subfoveal choroidal thickness (SFCT) and the diameters of superior temporal artery (STA), inferior temporal artery (ITA), superior temporal vein (STV), inferior temporal vein (ITV) were compared between the groups. Results: The baseline diameters of the STA, ITA were significantly decreased in the patient group compared with the control group (all p < .05). There was a significant increase at first month after the CCB treatment in comparison to baseline measurements (all p < .05). When compared with the controls, the diameter of venules showed a decrease at baseline but was not significant. After the treatment, the diameters of venules were insignificantly increased compared with baseline measurements (p = .178 and p = .275) and there were also no significant differences between the control group and the patient group in first month (all p > .05). The average choroidal thickness measurements of the hypertensive group was lower than the control group (p = .404) and there was a tendency to increase after the treatment (p = .055). Conclusion: This study demonstrates that, treatment with CCB seems to improve retinal arteries and has almost no affect on the choroidal thickness in newly diagnosed hypertensive patients.
Web of Science Eşleşmesi Bulundu
1
WoS Atıf
44
Cilt
Article
Belge Türü
Kaynak: CLINICAL AND EXPERIMENTAL HYPERTENSION · s. 649-655
Anahtar Kelimeler (WoS)

Havuzumuzdaki Atıflar 0

Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 1.

Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi Otomatik ISSN Eşleştirmesi 2022 yılı verileri
Clinical and Experimental Hypertension
Q3
SJR Quartile
0,438
SJR Skoru
57
H-Index
🔓
Açık Erişim
Kategoriler: Internal Medicine (Q3) · Medicine (miscellaneous) (Q3) · Physiology (Q3)
Alanlar: Biochemistry, Genetics and Molecular Biology · Medicine
Ülke: United States · Taylor and Francis Ltd.
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir. Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.

Anahtar Kelimeler

YÖKSİS WoS | Bir kelimeye tıklayıp ilgili kaynaktaki yayınları görün.

Makale Bilgileri

Dergi Clinical and experimental hypertension (New York, N.Y. : 1993)
ISSN 1064-1963
Yıl 2022 / 10. ay
Cilt / Sayı 44 / 7
Sayfalar 649 – 665
Makale Türü Özgün Makale
Hakemlik Hakemli
Endeks SCI-Expanded
JCR Quartile Q3
Teşvik Puanı 5,40 · YÖKSİS Akademik Teşvik
Yayın Dili İngilizce
Kapsam Uluslararası
Toplam Yazar 3 kişi
Erişim Türü Basılı+Elektronik
Alan Sağlık Bilimleri Temel Alanı Kardiyoloji Calcium channel blocker,choroidal thickness,optical coherence tomography,systemic hypertension

YÖKSİS Yazar Kaydı

Yazar Adı ÖZÇİMEN MUAMMER,TEZCAN HÜSEYİN,BÜYÜKTERZİ ZAFER
YÖKSİS ID 6601232

Metrikler

Scopus Atıf 1
Havuz Atıfları 0
JCR Quartile Q3
Teşvik Puanı 5,40
Yazar Sayısı 3